Special Issue "Drug Discovery and Development for Tropical Diseases (TDs)"
Deadline for manuscript submissions: closed (31 December 2021).
2. Medicinal Chemistry Institute—Spanish Council for Scientific Research, Madrid, Spain
Interests: medicinal chemistry; design and synthesis of antiparasitic agents for neglected tropical diseases (trypanosomiasis, leishmaniasis, malaria); cationic compounds; DNA binding study; pKa measurement
Special Issues, Collections and Topics in MDPI journals
Tropical diseases (TDs) cause immense human suffering and death. They represent a huge socioeconomic and life-threatening burden in less-developed countries. In the last 20 years, a great effort has been made by the international scientific community to tackle this problem and discover new safe and effective drugs against TDs, including the most neglected tropical diseases (NTDs) (https://www.who.int/teams/control-of-neglected-tropical-diseases). In this this Special Issue, we would like to provide a picture of the recent discoveries in the field of drug discovery for TDs. We will acknowledge research papers which topic includes, but is not restricted to, the design, synthesis, in vitro/in vivo evaluation, and development of new compounds for TDs, including promising chemotherapeutic targets to combat these diseases. Review articles outlining recent developments in the field are also welcome.
This special issue covers (but is not restricted to) the Tropical Diseases listed below:
- Buruli ulcer
- Chagas disease (American trypanosomiasis)
- Dracunculiasis (Guinea-worm disease)
- Foodborne trematode infections
- Human African trypanosomiasis (sleeping sickness)
- Leprosy (Hansen's disease)
- Lymphatic filariasis (Elephantiasis)
- Mycetoma, chromoblastomycosis, and other deep mycoses
- Onchocerciasis (river blindness)
- Scabies and other ectoparasitoses
- Schistosomiasis (Bilharzia)
- Soil-transmitted helminthiases
- Snakebite envenoming
- Taeniasis and cisticercosis
- Yaws (Endemic treponematoses)
Dr. Christophe Dardonville
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Tropical diseases (TDs)
- Neglected tropical diseases (NTDs)
- Drug discovery
- Medicinal chemistry
- Drug synthesis
- SAR studies
- in vitro/in vivo activity
- Chemotherapeutic targets